↓ Skip to main content

Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy

Overview of attention for article published in Breast Cancer Research and Treatment, December 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

blogs
1 blog
twitter
1 X user

Citations

dimensions_citation
144 Dimensions

Readers on

mendeley
113 Mendeley
Title
Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy
Published in
Breast Cancer Research and Treatment, December 2011
DOI 10.1007/s10549-011-1888-1
Pubmed ID
Authors

Vincent Koppelmans, Michiel B. de Ruiter, Fedde van der Lijn, Willem Boogerd, Caroline Seynaeve, Aad van der Lugt, Henri Vrooman, Wiro J. Niessen, Monique M. B. Breteler, Sanne B. Schagen

Abstract

A limited number of studies have associated adjuvant chemotherapy with structural brain changes. These studies had small sample sizes and were conducted shortly after cessation of chemotherapy. Results of these studies indicate local gray matter volume decrease and an increase in white matter lesions. Up till now, it is unclear if non-CNS chemotherapy is associated with long-term structural brain changes. We compared focal and total brain volume (TBV) of a large set of non-CNS directed chemotherapy-exposed breast cancer survivors, on average 21 years post-treatment, to that of a population-based sample of women without a history of cancer. Structural MRI (1.5T) was performed in 184 chemotherapy-exposed breast cancer patients, mean age 64.0 (SD = 6.5) years, who had been diagnosed with cancer on average 21.1 (SD = 4.4) years before, and 368 age-matched cancer-free reference subjects from a population-based cohort study. Outcome measures were: TBV and total gray and white matter volume, and hippocampal volume. In addition, voxel based morphometry was performed to analyze differences in focal gray matter. The chemotherapy-exposed breast cancer survivors had significantly smaller TBV (-3.5 ml, P = 0.019) and gray matter volume (-2.9 ml, P = 0.003) than the reference subjects. No significant differences were observed in white matter volume, hippocampal volume, or local gray matter volume. This study shows that adjuvant chemotherapy for breast cancer is associated with long-term reductions in TBV and overall gray matter volume in the absence of focal reductions. The observed smaller gray matter volume in chemotherapy-exposed survivors was comparable to the effect of almost 4 years of age on gray matter volume reduction. These volume differences might be associated with the slightly worse cognitive performance that we observed previously in this group of breast cancer survivors.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 113 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Portugal 1 <1%
Canada 1 <1%
Unknown 111 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 23 20%
Researcher 15 13%
Student > Master 14 12%
Student > Bachelor 11 10%
Student > Doctoral Student 9 8%
Other 21 19%
Unknown 20 18%
Readers by discipline Count As %
Medicine and Dentistry 23 20%
Psychology 20 18%
Neuroscience 18 16%
Agricultural and Biological Sciences 10 9%
Nursing and Health Professions 4 4%
Other 14 12%
Unknown 24 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 October 2018.
All research outputs
#2,584,696
of 22,661,413 outputs
Outputs from Breast Cancer Research and Treatment
#393
of 4,612 outputs
Outputs of similar age
#20,850
of 243,631 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#5
of 54 outputs
Altmetric has tracked 22,661,413 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,612 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 243,631 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 54 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.